The SPAC said merger partner Clever Leaves, a multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, has entered into a $4 million commercial agreement with pharmaceutical company GreenCare to license and distribute certain Clever Leaves’ white label cannabis-derived products. Manufacturing will occur in Clever Leaves’ facilities in Colombia. An initial payment of $2 million has already been made, the companies said. Read more.
Related Posts
Therapeutics Acquistion Shareholders Approve $924M POINT Biopharma Deal
The combined company is expected to receive net proceeds of approximately $300 million at the closing of the transaction, including a $165 million PIPE .
G&P Acquisition Prices $175M IPO
G&P intends to focus its search on investment opportunities in the food and beverage, consumer goods, automotive and hospitality sectors.
Adara Acquisition Files Prelim Proxy on $480M Alliance Entertainment Deal
If approved, the combined business is expected to have a proforma equity value of approximately $480 million and $109 million in gross cash proceeds after closing.
Brookline Capital Acquisition Sponsor Sweetens Trust, Grants Loan
Brookline shareholders approved a merger deadline extension last week, although redemptions ahead of the shareholder vote erased 12% of Brookline’s trust.